Claranova SE (EPA:CLA) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

The quarterly results for Claranova SE (EPA:CLA) were released last week, making it a good time to revisit its performance. It was a credible result overall, with revenues of €193m and statutory earnings per share of €0.27 both in line with analyst estimates, showing that Claranova is executing in line with expectations. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.

See our latest analysis for Claranova

Taking into account the latest results, the current consensus from Claranova's five analysts is for revenues of €491.3m in 2022, which would reflect a satisfactory 3.5% increase on its sales over the past 12 months. Statutory earnings per share are predicted to jump 236% to €0.36. Before this earnings report, the analysts had been forecasting revenues of €492.8m and earnings per share (EPS) of €0.34 in 2022. So the consensus seems to have become somewhat more optimistic on Claranova's earnings potential following these results.

There's been no major changes to the consensus price target of €8.65, suggesting that the improved earnings per share outlook is not enough to have a long-term positive impact on the stock's valuation. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. The most optimistic Claranova analyst has a price target of €10.50 per share, while the most pessimistic values it at €7.50. These price targets show that analysts do have some differing views on the business, but the estimates do not vary enough to suggest to us that some are betting on wild success or utter failure.

One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. We would highlight that Claranova's revenue growth is expected to slow, with the forecast 7.2% annualised growth rate until the end of 2022 being well below the historical 30% p.a. growth over the last five years. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 9.7% per year. So it's pretty clear that, while revenue growth is expected to slow down, the wider industry is also expected to grow faster than Claranova.

The Bottom Line

The biggest takeaway for us is the consensus earnings per share upgrade, which suggests a clear improvement in sentiment around Claranova's earnings potential next year. On the plus side, there were no major changes to revenue estimates; although forecasts imply revenues will perform worse than the wider industry. The consensus price target held steady at €8.65, with the latest estimates not enough to have an impact on their price targets.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. At Simply Wall St, we have a full range of analyst estimates for Claranova going out to 2024, and you can see them free on our platform here..

That said, it's still necessary to consider the ever-present spectre of investment risk. We've identified 4 warning signs with Claranova , and understanding these should be part of your investment process.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.